Literature DB >> 21530304

Growth hormone-releasing hormone: not only a neurohormone.

Hippokratis Kiaris1, Ioulia Chatzistamou, Athanasios G Papavassiliou, Andrew V Schally.   

Abstract

Growth hormone-releasing hormone (GHRH) is mostly thought to act by stimulating the production and release of growth hormone from the pituitary. However, this neuropeptide emerges as a rather pleiotropic hormone in view of the identification of various extrapituitary sources for GHRH production, as well as the demonstration of a direct action of GHRH on several tissues other than the pituitary. Non-pituitary GHRH has a wide spectrum of activity, exemplified by its ability to modulate cell proliferation, especially in malignant tissues, to regulate differentiation of some cell types, and to promote healing of skin wounds. These findings extend the role of GHRH and its analogs beyond its accepted regulation of somatotropic activity and indicate new possibilities for therapeutic intervention.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530304     DOI: 10.1016/j.tem.2011.03.006

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  38 in total

1.  Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Authors:  Ferenc G Rick; Andrew V Schally; Luca Szalontay; Norman L Block; Karoly Szepeshazi; Mehrdad Nadji; Marta Zarandi; Florian Hohla; Stefan Buchholz; Stephan Seitz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-18       Impact factor: 11.205

2.  Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema.

Authors:  Rudolf Lucas; Supriya Sridhar; Ferenc G Rick; Boris Gorshkov; Nagavedi S Umapathy; Guang Yang; Aluya Oseghale; Alexander D Verin; Trinad Chakraborty; Michael A Matthay; Evgeny A Zemskov; Richard White; Norman L Block; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  The PNEI holistic approach in coloproctology.

Authors:  M Pescatori; V Podzemny; L C Pescatori; M P Dore; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-03-29       Impact factor: 3.781

4.  Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.

Authors:  Nikolina Dioufa; Elena Farmaki; Andrew V Schally; Hippokratis Kiaris; Dimitris Vlahodimitropoulos; Athanasios G Papavassiliou; Christos Kittas; Norman L Block; Ioulia Chatzistamou
Journal:  Horm Cancer       Date:  2012-03-23       Impact factor: 3.869

5.  Pituitary miRNAs target GHRHR splice variants to regulate GH synthesis by mediating different intracellular signalling pathways.

Authors:  Yunyun Cheng; Ting Chen; Jie Song; Zhaohui Teng; Chunli Wang; Siyao Wang; Guanhong Lu; Tianqi Feng; Qien Qi; Qianyun Xi; Songcai Liu; Linlin Hao; Yongliang Zhang
Journal:  RNA Biol       Date:  2020-06-19       Impact factor: 4.652

6.  GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.

Authors:  Ferenc G Rick; Stephan Seitz; Andrew V Schally; Luca Szalontay; Awtar Krishan; Christian Datz; Andreas Stadlmayr; Stefan Buchholz; Norman L Block; Florian Hohla
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

7.  A glimpse at growth hormone-releasing hormone cosmos.

Authors:  Nektarios Barabutis
Journal:  Clin Exp Pharmacol Physiol       Date:  2020-04-25       Impact factor: 2.557

8.  Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation.

Authors:  Yong Jie Qin; Sun On Chan; Kelvin Kam Lung Chong; Benjamin Fuk Loi Li; Tsz Kin Ng; Yolanda Wong Ying Yip; Haoyu Chen; Mingzhi Zhang; Norman L Block; Herman S Cheung; Andrew V Schally; Chi Pui Pang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

9.  Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Authors:  Luca Szalontay; Andrew V Schally; Petra Popovics; Irving Vidaurre; Awtar Krishan; Marta Zarandi; Ren-Zhi Cai; Anna Klukovits; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats.

Authors:  Douglas A Weigent
Journal:  Cell Immunol       Date:  2013-05-03       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.